|
Office of Extramural Affairs Grant Review Committees
|
| Code |
Name of
Subcommittee |
Scientific Review Administrator |
Research Areas |
| NIDA/E |
Treatment |
Kristen Huntley, Ph.D.,
Scientific Review Officer,
#301-435-1433
huntleyk@nida.nih.gov |
Behavioral and/or pharmacologic treatment, medication application, and marketed medications clinical trials |
| NIDA/F |
Health Services |
Meena Hiremath, Ph.D.
#301-402-7964
hirematm@nida.nih.gov
|
Health services research including the organization, management, financing, delivery, effectiveness, and impact of the drug abuse health services delivery system |
| NIDA/K |
Training and Career Development |
Eliane Lazar-Wesley, Ph.D.
#301/451-4530
elazarwe@nida.nih.gov |
Review grant applications for career development and institutional training in all areas of drug abuse research |
| NIDA/L |
Medication Development |
Jose Ruiz, Ph.D.
#301-451-3086
ruizjf@nida.nih.gov
|
Review grant and cooperative agreement applications that propose to design and develop compounds and dosage formulations related to the discovery of new pharmacotherapeutic agents for treating drug dependence |
| ZDA1 |
Special
Emphasis Panel (SEP) |
Varies |
Special Emphasis Panels (SEPS) are committees that meet for a special purpose, such as the review of RFA applications, Center applications, or applications in conflict-of-interest with one of the standing committees. |
|
Click here for rosters of review
groups that are managed by the Center for Scientific Review or other
Institutes.
For general committee information contact:
Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.
For specific committee information contact the Scientific Review Administrator listed above.
Office Address:
National Institute on Drug Abuse Initial Review Group
Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
Atrium Building
6101 Executive Boulevard
Room 200, MSC 8401
Bethesda, Maryland 20892-8401
FAQ's for Grants and Contracts
|
|
|
